Universal Biology Unveiled: Landmark Study Confirms Autism Risk Genes Are Shared Across All Ancestries

A groundbreaking genomic study published on March 30, 2026, in Nature Medicine has delivered compelling evidence that the core genetic drivers of autism spectrum disorder (ASD) operate identically regardless of ancestry. Led by researchers at the Icahn School of Medicine at Mount Sinai through the Genomics of Autism in Latin American Ancestries (GALA) Consortium, the analysis of more than 15,000 Latin American individuals demonstrates substantial overlap in autism-linked genes with prior European-focused research—and finds no detectable ancestry-specific effects on the underlying biology.

Background: Closing the Diversity Gap in Autism Genetics

For years, large-scale autism gene-discovery efforts have primarily included individuals of European ancestry, raising concerns about whether findings would translate to other populations. Latin American groups, with their rich admixed ancestry (primarily Indigenous American, European, and West African origins), represent an ideal test case for evaluating genetic universality. The GALA Consortium was established specifically to address this gap, recruiting participants across North, Central, and South America and integrating data from the broader Autism Sequencing Consortium. Prior studies had identified dozens of genes where rare, deleterious coding variants dramatically increase autism risk. However, without diverse cohorts, it remained unclear whether these associations held across ancestries or if population-specific genetic architecture might alter risk profiles.

Study Design and Methods

The GALA team analyzed whole-exome sequencing (primarily) and some whole-genome sequencing data from 15,427 Latin American individuals, including 4,717 diagnosed with autism (ASD probands), unaffected siblings, and parents. This makes it one of the largest sequencing studies of autism in any non-European population to date. Participants were drawn from multiple collection sites spanning the Americas, reflecting the Admixed American (AMR) superpopulation. Researchers examined over 18,000 genes for enrichment of rare, deleterious coding variants (such as loss-of-function or missense changes predicted to disrupt protein function). They applied rigorous statistical frameworks, including family-based analyses and comparisons to ancestry-matched controls, while accounting for evolutionary constraint (how intolerant genes are to mutation). They also directly compared results to large European-ancestry datasets.

Key Findings: Striking Consistency Across Populations

The study identified 35 genes reaching genome-wide significance (false discovery rate < 0.05) for association with autism in the Latin American cohort. These genes showed extensive overlap with those previously implicated in European-ancestry studies: 19 of the 35 GALA genes exhibited strong signals in non-AMR (predominantly European) cohorts. Highly constrained genes—those critical for brain development and intolerant to mutation—displayed consistent risk signals regardless of ancestry. Notable genes reinforced or newly supported include both established autism risk factors (e.g., SYNGAP1, MTOR) and emerging ones such as MARK2, YWHAG, PACS1, RERE, SPEN, GSE1, GLS, TNPO3, and ANKRD17. De novo variant rates (new mutations arising in the child) in Latin American individuals aligned closely with patterns observed in other ancestry groups. Crucially, the authors found no evidence that ancestry modifies the biology: rare deleterious variants in the same highly conserved genes drive risk uniformly. Metrics of gene constraint (largely derived from European data) proved highly accurate for the most critical autism-related genes, though the study notes that broader diversity will further refine these tools for less-constrained genes.

Implications: Advancing Equity in Precision Medicine

Senior author Joseph D. Buxbaum, PhD, Director of the Seaver Autism Center for Research and Treatment at Mount Sinai, emphasized the universality: “Our results indicate that the core genetic architecture of autism is shared across ancestries. This suggests that the biology underlying autism is universal and reinforces the importance of ensuring that diverse populations are represented in genetic research.” He added that the findings provide “a road map for improving genetic diagnosis across ancestral groups” and are essential for reducing health disparities. The results affirm that existing genetic testing pipelines—focused on deleterious variants—should work effectively across backgrounds when paired with diverse allele-frequency reference data. This has immediate clinical relevance: individuals from underrepresented ancestries currently face higher rates of inconclusive genetic test results. By validating shared biology, the study supports more equitable access to diagnosis, counseling, and emerging precision therapies. Broader scientific impact includes strengthening confidence in cross-ancestry gene-disease associations for autism and related neurodevelopmental disorders. The authors also highlight the ongoing need for inclusive research: continued sequencing of diverse populations will improve variant classification and evolutionary metrics.

A Universal Foundation for Autism Research

This GALA Consortium study delivers definitive proof that the genetic roots of autism transcend ancestry. As the paper concludes: “We conclude that the biology of autism is consistent across populations, with no detectable influence of ancestry.” By focusing on one of the world’s most genetically admixed populations, researchers have not only filled a critical diversity void but also reinforced the shared human biology of neurodevelopment. The findings mark a pivotal step toward precision medicine that benefits everyone—regardless of background—while underscoring the scientific and ethical imperative to include all populations in genomic discovery.

Citations

1. Avila, M. N. et al. (2026). Deleterious coding variation associated with autism is shared across ancestries. Nature Medicine. https://doi.org/10.1038/s41591-026-04228-6 (Primary research article).
2. Mount Sinai Health System. (March 30, 2026). New Research Reveals Autism Risk Genes Are Shared Across Ancestries [Press Release]. https://www.mountsinai.org/about/newsroom/2026/new-research-reveals-autism-risk-genes-are-shared-across-ancestries.
3. Nature Medicine Research Briefing. (2026). Genes that increase the risk of autism are shared across ancestries. https://www.nature.com/articles/s41591-026-04259-z.

Additional context drawn from GALA Consortium descriptions and related coverage in The Transmitter and other outlets.